Skip to Content

Emmaus Life Sciences Inc EMMA Stock Quote

| Rating as of

PINX: EMMA

Market Closed

| Currency in USD

  • Last Close 0.15
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Blend
  • Day Range 0.15  –  0.15
  • Year Range 0.07  –  0.52
  • Market Cap 8.0456 Mil
  • Volume / Avg 2,000.0 /  26,854.2
  • Price / Sales 0.27
  • Price / Book
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis EMMA

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics EMMA

Company Profile EMMA

Business Description

Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.

Contact
21250 Hawthorne Boulevard, Suite 800
Torrance, CA, 90503
Industry Biotechnology
Employees 55

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Emmaus Life Sciences Inc

PINX: EMMA

Immuron Ltd

XASX: IMC

MediciNova Inc

XNAS: MNOV

Ultragenyx Pharmaceutical Inc

XNAS: RARE
Price
0.150.082.0936.43
Currency
USDAUDUSDUSD
Change
+$0.01 (7.26%) $0.00 (2.50%) +$0.08 (3.98%) −$0.18 (0.49%)
Market Cap
8.05 Mil17.77 Mil102.51 Mil2.60 Bil
Industry
Biotechnology Biotechnology Biotechnology Biotechnology
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Emmaus Life Sciences Inc Stock

No. EMMA does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

EMMA’s market cap is 8.05 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

EMMA’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

EMMA’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare EMMA’s historical performance against its industry peers and the overall market.